Search Results - "Feig, Barry W."

Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer by Park, In Ja, You, Y Nancy, Agarwal, Atin, Skibber, John M, Rodriguez-Bigas, Miguel A, Eng, Cathy, Feig, Barry W, Das, Prajnan, Krishnan, Sunil, Crane, Christopher H, Hu, Chung-Yuan, Chang, George J

“…Neoadjuvant chemoradiotherapy for rectal cancer is associated with improved local control and may result in complete tumor response. Associations between tumor…”
Get full text

Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base by Hyngstrom, John R., Hu, Chung-Yuan, Xing, Yan, You, Y. Nancy, Feig, Barry W., Skibber, John M., Rodriguez-Bigas, Miguel A., Cormier, Janice N., Chang, George J.

“…Purpose We evaluated clinical features and survival outcomes among patients with signet ring and mucinous histologies of colorectal adenocarcinoma by using…”
Get full text

DNA Mismatch Repair Deficiency in Rectal Cancer: Benchmarking Its Impact on Prognosis, Neoadjuvant Response Prediction, and Clinical Cancer Genetics by de Rosa, Nicole, Rodriguez-Bigas, Miguel A, Chang, George J, Veerapong, Jula, Borras, Ester, Krishnan, Sunil, Bednarski, Brian, Messick, Craig A, Skibber, John M, Feig, Barry W, Lynch, Patrick M, Vilar, Eduardo, You, Y Nancy

“…DNA mismatch repair deficiency (dMMR) hallmarks consensus molecular subtype 1 of colorectal cancer. It is being routinely tested, but little is known about…”
Get full text

Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma by Keung, Emily Z., Chiang, Yi-Ju, Voss, Rachel K., Cormier, Janice N., Torres, Keila E., Hunt, Kelly K., Feig, Barry W., Roland, Christina L.

“…The incidence and clinical significance of lymph node metastasis (LNM, N1) in soft tissue sarcoma (STS) is unclear. Recent studies have focused on…”
Get full text

Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival by Subbiah, Vivek, Lamhamedi-Cherradi, Salah-Eddine, Cuglievan, Branko, Menegaz, Brian A, Camacho, Pamela, Huh, Winston, Ramamoorthy, Vandhana, Anderson, Pete M, Pollock, Raphael E, Lev, Dina C, Qiao, Wei, McAleer, Mary Frances, Benjamin, Robert S, Patel, Shreyaskumar, Herzog, Cynthia E, Daw, Najat C, Feig, Barry W, Lazar, Alexander J, Hayes-Jordan, Andrea, Ludwig, Joseph A

“…Desmoplastic small round cell tumor (DSRCT), which harbors EWSR1-WT1 t(11;22)(p13:q12) chromosomal translocation, is an aggressive malignancy that typically…”
Get full text

Adherence to Stage-Specific Treatment Guidelines for Patients With Colon Cancer by CHAGPAR, Ryaz, YAN XING, CHIANG, Yi-Ju, FEIG, Barry W, CHANG, George J, NANCY YOU, Y, CORMIER, Janice N

“…Adherence to evidence-based treatment guidelines has been proposed as a measure of cancer care quality. We sought to determine rates of and factors associated…”
Get full text

Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors by Watson, Kelsey L, Al Sannaa, Ghadah A, Kivlin, Christine M, Ingram, Davis R, Landers, Sharon M, Roland, Christina L, Cormier, Janice N, Hunt, Kelly K, Feig, Barry W, Ashleigh Guadagnolo, B, Bishop, Andrew J, Wang, Wei-Lien, Slopis, John M, McCutcheon, Ian E, Lazar, Alexandar J, Torres, Keila E

“…OBJECTIVE Malignant peripheral nerve sheath tumors (MPNSTs) are an aggressive group of soft tissue sarcomas that can arise sporadically, in the context of…”
Get full text

Phase II Trial of Neoadjuvant Bevacizumab, Capecitabine, and Radiotherapy for Locally Advanced Rectal Cancer by Crane, Christopher H., M.D, Eng, Cathy, M.D, Feig, Barry W., M.D, Das, Prajnan, M.D, Skibber, John M., M.D, Chang, George J., M.D, Wolff, Robert A., M.D, Krishnan, Sunil, M.D, Hamilton, Stanley, M.D, Janjan, Nora A., M.D, Maru, Dipen M., M.D, Ellis, Lee M., M.D, Rodriguez-Bigas, Miguel A., M.D

“…Purpose We designed this Phase II trial to assess the efficacy and safety of the addition of bevacizumab to concurrent neoadjuvant capecitabine-based…”
Get full text

Impact of Ileostomy-Related Complications on the Multidisciplinary Treatment of Rectal Cancer by Phatak, Uma R., Kao, Lillian S., You, Y. Nancy, Rodriguez-Bigas, Miguel A., Skibber, John M., Feig, Barry W., Nguyen, Sa, Cantor, Scott B., Chang, George J.

“…Background Radical resection is the primary treatment for rectal cancer. When anastomosis is possible, a temporary ileostomy is used to decrease morbidity from…”
Get full text

Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership by Witt, Russell G., Voss, Rachel K., Chiang, Yi-Ju, Nguyen, Sa, Scally, Christopher P., Lin, Patrick P., Torres, Keila E., Moon, Bryan S., Satcher, Robert L., Hunt, Kelly K., Bird, Justin E., Feig, Barry W., Lewis, Valerae O., Roland, Christina L., Keung, Emily Z.

“…Background Regional lymph node metastasis in extremity and trunk soft tissue sarcoma (ETSTS) is rare with no standardized management. We sought to determine…”
Get full text

Prospective Evaluation of the Nipple–Areola Complex Sparing Mastectomy for Risk Reduction and for Early-Stage Breast Cancer by Wagner, Jamie L., Fearmonti, Regina, Hunt, Kelly K., Hwang, Rosa F., Meric-Bernstam, Funda, Kuerer, Henry M., Bedrosian, Isabelle, Crosby, Melissa A., Baumann, Donald P., Ross, Merrick I., Feig, Barry W., Krishnamurthy, Savitri, Hernandez, Mike, Babiera, Gildy V.

“…Background Psychological effects of mastectomy for women with breast cancer have driven treatments that optimize cosmesis while strictly adhering to oncologic…”
Get full text

Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer by Das, Prajnan, Skibber, John M., Rodriguez‐Bigas, Miguel A., Feig, Barry W., Chang, George J., Wolff, Robert A., Eng, Cathy, Krishnan, Sunil, Janjan, Nora A., Crane, Christopher H.

“…BACKGROUND The objective of this study was to identify predictive factors for pathologic complete response and tumor downstaging after preoperative…”
Get full text

ASO Visual Abstract: Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma (ETSTS): A Survey of the Society of Surgical Oncology (SSO) and Musculoskeletal Tumor Society (MSTS) Membership by Witt, Russell G., Voss, Rachel K., Chiang, Yi-Ju, Nguyen, Sa, Scally, Christopher P., Lin, Patrick P., Torres, Keila E., Moon, Bryan S., Satcher, Robert L., Hunt, Kelly K., Bird, Justin E., Feig, Barry W., Lewis, Valerae O., Roland, Christina L., Keung, Emily Z.

Get full text

Dermatofibrosarcoma Protuberans: Long-term Outcomes of 53 Patients Treated With Conservative Surgery and Radiation Therapy by Castle, Katherine O., MD, Guadagnolo, B. Ashleigh, MD, MPH, Tsai, C. Jillian, MD, PhD, Feig, Barry W., MD, Zagars, Gunar K., MD

“…Purpose To evaluate outcomes of conservative surgery and radiation therapy (RT) treatment in patients with dermatofibrosarcoma protuberans. Methods and…”
Get full text

Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state by Kochat, Veena, Raman, Ayush T., Landers, Sharon M., Tang, Ming, Schulz, Jonathan, Terranova, Christopher, Landry, Jace P., Bhalla, Angela D., Beird, Hannah C., Wu, Chia-Chin, Jiang, Yingda, Mao, Xizeng, Lazcano, Rossana, Gite, Swati, Ingram, Davis R., Yi, Min, Zhang, Jianhua, Keung, Emily Z., Scally, Christopher P., Roland, Christina L., Hunt, Kelly K., Feig, Barry W., Futreal, P. Andrew, Hwu, Patrick, Wang, Wei-Lien, Lazar, Alexander J., Slopis, John M., Wilson-Robles, Heather, Wiener, Dominique J., McCutcheon, Ian E., Wustefeld-Janssens, Brandan, Rai, Kunal, Torres, Keila E.

“…Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas that frequently harbor genetic alterations in polycomb repressor complex 2 (PRC2)…”
Get full text

Preoperative Bevacizumab Does Not Significantly Increase Postoperative Complication Rates in Patients Undergoing Hepatic Surgery for Colorectal Cancer Liver Metastases by KESMODEL, Susan B, ELLIS, Lee M, LIN, E, CHANG, George J, ABDALLA, Eddie K, KOPETZ, Scott, VAUTHEY, Jean-Nicolas, RODRIGUEZ-BIGAS, Miguel A, CURLEY, Steven A, FEIG, Barry W

“…Although bevacizumab (BV) increases survival rates when used with chemotherapy (CTX) in patients who have metastatic colorectal cancer (CRC), an increase in…”
Get full text

Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery by Ikoma, Naruhiko, Torres, Keila E., Lin, Heather Y., Ravi, Vinod, Roland, Christina L., Mann, Gary N., Hunt, Kelly K., Cormier, Janice N., Feig, Barry W.

“…Background Optimal treatment strategies for retroperitoneal leiomyosarcoma (RPLMS), particularly recurrent disease, are unknown. Methods We searched the tumor…”
Get full text

Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases by Goumard, Claire, Marcal, Leonardo P., Wang, Wei-Lien, Somaiah, Neeta, Okuno, Masayuki, Roland, Christina L., Tzeng, Ching-Wei D., Chun, Yun Shin, Feig, Barry W., Vauthey, Jean-Nicolas, Conrad, Claudius

“…Background Non-gastrointestinal stromal tumor sarcomas (NGSs) have heterogeneous histology, and this heterogeneity may lead to uncertainty regarding the…”
Get full text

ACR Appropriateness Criteria® Pretreatment Staging of Colorectal Cancer by Fowler, Kathryn J., MD, Kaur, Harmeet, MD, Cash, Brooks D., MD, Feig, Barry W., MD, Gage, Kenneth L., MD, Garcia, Evelyn M., MD, Hara, Amy K., MD, Herman, Joseph M., MD, MSc, Kim, David H., MD, Lambert, Drew L., MD, Levy, Angela D., MD, Peterson, Christine M., MD, Scheirey, Christopher D., MD, Small, William, MD, Smith, Martin P., MD, Lalani, Tasneem, MD, Carucci, Laura R., MD

“…Abstract Colorectal cancers are common tumors in the United States and appropriate imaging is essential to direct appropriate care. Staging and treatment…”
Get full text

Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma by Roland, Christina L, Boland, Genevieve M, Demicco, Elizabeth G, Lusby, Kristelle, Ingram, Davis, May, Caitlin D, Kivlin, Christine M, Watson, Kelsey, Al Sannaa, Ghadah A, Wang, Wei-Lien, Ravi, Vinod, Pollock, Raphael E, Lev, Dina, Cormier, Janice N, Hunt, Kelly K, Feig, Barry W, Lazar, Alexander J, Torres, Keila E

“…Vascular leiomyosarcomas are a rare subtype of leiomyosarcomas that most commonly affect the inferior vena cava and account for 5% of all leiomyosarcomas…”
Get more information